Skip to content

Investigating the effect of probiotic supplements on uremic pruritus in patients undergoing hemodialysis.

Investigating the effect of Streptococcus thermophilus, Lactiplantibacillus plantarum and the combination of these two probiotics on uremic pruritus in patients undergoing hemodialysis : A double-blind randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201005048927N1
Enrollment
56
Registered
2025-04-27
Start date
2025-03-21
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: chronic kidney disease. Condition 2: uremic pruritus. Chronic kidney disease (CKD) Pruritus, unspecified

Interventions

Intervention 1: Intervention group:Lactiplantibacillus plantarum group: Oral medication in the form of drops equivalent to CFU=1*109 of Lactiplantibacillus plantarum bacteria administered daily for 12

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years Continuous hemodialysis for more than three months They should have suffered from itching for at least 6 weeks.

Exclusion criteria

Exclusion criteria: Liver disease History of seizures Skin disease associated with itching Hemolytic blood disease First complaint of itching Use of any type of antibiotic Participation in another clinical trial in the past month pregnancy active cancer Active infection Sensitivity to probiotic compounds

Design outcomes

Primary

MeasureTime frame
Uremic pruritus( method of Scale Analogue Visual and the Persian version of the 5-Scale Itching Questionnaire). Timepoint: At the beginning of the study (before the intervention starts), during the intervention (6 weeks after the intervention starts), and after the intervention (immediately after 12 weeks from the start of the intervention). Method of measurement: To assess itching, the Scale Analogue Visual method and the Persian version of the 5-Scale Itching Questionnaire, whose validity and reliability have been confirmed by Yousef Nejad, will be used.

Secondary

MeasureTime frame
C-REACTIVE PROTEIN. Timepoint: At the beginning of the study (before the intervention starts) and at the end of the intervention (after completing 12 weeks). Method of measurement: ELISA.;Interlukine-6. Timepoint: At the beginning of the study (before the intervention starts) and at the end of the intervention (after completing 12 weeks). Method of measurement: ELISA.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahboobe Rastgoo

Shiraz University of Medical Sciences

mahboob.rastgoo@gmail.com+98 71 3225 3578

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026